Robert W. Duggan, Chief Executive Officer at Summit Therapeutics Inc. (SMMT), bought 376,489,880 shares at $1.05 ($395.3M) on 2023-03-06, disclosed to the SEC on 2023-03-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |